|
2025-04-11 |
2025-04-11 |
S
Sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
50,800
-1.3%
11.49
USD 583,692
|
50,800
-1.3%
|
11.49
|
USD 583,692
|
|
|
2025-04-11 |
2025-04-10 |
S
Sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
50,000
-1.2%
10.87
USD 543,500
|
50,000
-1.2%
|
10.87
|
USD 543,500
|
|
|
2025-04-11 |
2025-04-09 |
S
Sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
1,617
-0.0%
11.76
USD 19,016
|
1,617
-0.0%
|
11.76
|
USD 19,016
|
|
|
2025-04-11 |
2025-04-09 |
S
Sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
3,400
-0.1%
10.75
USD 36,550
|
3,400
-0.1%
|
10.75
|
USD 36,550
|
|
|
2025-04-11 |
2025-04-09 |
S
Sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
35,305
-0.9%
9.93
USD 350,579
|
35,305
-0.9%
|
9.93
|
USD 350,579
|
|
|
2025-03-17 |
2025-03-13 |
S
Sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
51,425
-1.3%
15.07
USD 774,975
|
51,425
-1.3%
|
15.07
|
USD 774,975
|
|
|
2025-03-05 |
2025-03-04 |
PS
Planned sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
133,333
-3.4%
17.02
USD 2,269,328
|
133,333
-3.4%
|
17.02
|
USD 2,269,328
|
|
|
2025-03-05 |
2025-03-03 |
PS
Planned sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
166,667
-4.1%
18.03
USD 3,005,006
|
166,667
-4.1%
|
18.03
|
USD 3,005,006
|
|
|
2025-01-27 |
2025-01-23 |
PS
Planned sale
|
OLUKOTUN ADEOYE Y
Non-Executive Director
|
959
-2.6%
21.00
USD 20,139
|
959
-2.6%
|
21.00
|
USD 20,139
|
|
|
2025-01-07 |
2025-01-07 |
PS
Planned sale
|
O'Brien Patrick
COO and General Counsel
Officer
|
8,000
-1.5%
19.69
USD 157,520
|
8,000
-1.5%
|
19.69
|
USD 157,520
|
|
|
2025-01-07 |
2025-01-07 |
S
Sale
|
Myszkowski Kenneth Allen
Chief Financial Officer
Officer
|
10,000
-2.1%
19.69
USD 196,900
|
10,000
-2.1%
|
19.69
|
USD 196,900
|
|
|
2025-01-07 |
2025-01-07 |
PS
Planned sale
|
Myszkowski Kenneth Allen
Chief Financial Officer
Officer
|
8,000
-1.7%
19.70
USD 157,600
|
8,000
-1.7%
|
19.70
|
USD 157,600
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
O'Brien Patrick
COO and General Counsel
Officer
|
9,526
-1.7%
20.10
USD 191,473
|
9,526
-1.7%
|
20.10
|
USD 191,473
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
O'Brien Patrick
COO and General Counsel
Officer
|
19,658
-3.5%
19.69
USD 387,066
|
19,658
-3.5%
|
19.69
|
USD 387,066
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
Myszkowski Kenneth Allen
Chief Financial Officer
Officer
|
9,402
-1.9%
20.10
USD 188,980
|
9,402
-1.9%
|
20.10
|
USD 188,980
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
Myszkowski Kenneth Allen
Chief Financial Officer
Officer
|
17,765
-3.5%
19.68
USD 349,615
|
17,765
-3.5%
|
19.68
|
USD 349,615
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
Hamilton James C
Chief Discovery/Trans Medicine
Officer
|
10,971
-3.9%
20.11
USD 220,627
|
10,971
-3.9%
|
20.11
|
USD 220,627
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
Hamilton James C
Chief Discovery/Trans Medicine
Officer
|
21,758
-7.1%
19.68
USD 428,197
|
21,758
-7.1%
|
19.68
|
USD 428,197
|
|
|
2025-01-06 |
2025-01-02 |
PS
Planned sale
|
Anzalone Christopher Richard
Chief Executive Officer
Executive Director
|
11,520
-0.3%
19.05
USD 219,456
|
11,520
-0.3%
|
19.05
|
USD 219,456
|
|
|
2024-12-30 |
2024-12-27 |
PS
Planned sale
|
OLUKOTUN ADEOYE Y
Non-Executive Director
|
2,850
-7.2%
20.00
USD 57,000
|
2,850
-7.2%
|
20.00
|
USD 57,000
|
|
